ITRM940322A0 - "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". - Google Patents

"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".

Info

Publication number: ITRM940322A0
Authority: IT; Italy
Prior art keywords: carbazolone; migraine; preparation; treatment; pharmaceutical composition
Prior art date: 1993-05-25

Application number

ITRM940322A

Other languages

English (en)

Inventor

Isabelle Thielemans

Isabelle Richard

Original Assignee

Glaxo Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-25

Filing date

1994-05-24

Publication date

1994-05-24

1994-05-24 Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa

1994-05-24 Publication of ITRM940322A0 publication Critical patent/ITRM940322A0/it

1995-11-24 Publication of ITRM940322A1 publication Critical patent/ITRM940322A1/it

1997-07-01 Application granted granted Critical

1997-07-01 Publication of IT1272990B publication Critical patent/IT1272990B/it

Links

208000028017 Psychotic disease Diseases 0.000 title 1
AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical compound C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

ITRM940322A 1993-05-25 1994-05-24 "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". IT1272990B (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939310756A GB9310756D0 (en)	1993-05-25	1993-05-25	Compositions

Publications (3)

Publication Number	Publication Date
ITRM940322A0 true ITRM940322A0 (it)	1994-05-24
ITRM940322A1 ITRM940322A1 (it)	1995-11-24
IT1272990B IT1272990B (it)	1997-07-01

Family

ID=10736089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ITRM940322A IT1272990B (it)	1993-05-25	1994-05-24	"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".

Country Status (38)

Country	Link
US (1)	US5741806A (it)
EP (1)	EP0700290B1 (it)
JP (1)	JP2965703B2 (it)
KR (1)	KR100297212B1 (it)
CN (1)	CN1106194C (it)
AP (1)	AP544A (it)
AT (1)	ATE183643T1 (it)
AU (1)	AU680918B2 (it)
BE (1)	BE1007158A3 (it)
BR (1)	BR1100046A (it)
CA (1)	CA2162919C (it)
CO (1)	CO4230094A1 (it)
CY (1)	CY2411B1 (it)
CZ (1)	CZ291041B6 (it)
DE (1)	DE69420266T2 (it)
DK (1)	DK0700290T3 (it)
EC (1)	ECSP941088A (it)
ES (1)	ES2136198T3 (it)
FR (1)	FR2705569B1 (it)
GB (2)	GB9310756D0 (it)
GR (1)	GR3031669T3 (it)
HR (2)	HRP940315B1 (it)
HU (1)	HU227121B1 (it)
IE (1)	IE80632B1 (it)
IL (1)	IL109749A (it)
IS (1)	IS1868B (it)
IT (1)	IT1272990B (it)
MY (1)	MY111445A (it)
NO (1)	NO306448B1 (it)
NZ (1)	NZ267415A (it)
PE (1)	PE13395A1 (it)
PL (1)	PL175578B1 (it)
RU (1)	RU2132684C1 (it)
SA (1)	SA94150003B1 (it)
SG (1)	SG48119A1 (it)
SI (1)	SI0700290T1 (it)
WO (1)	WO1994027599A1 (it)
ZA (1)	ZA943593B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200103057T2 (tr)	1998-06-15	2002-06-21	Sepracor Inc.	Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı
EP1468685A3 (en) *	1998-06-15	2004-12-15	Sepracor Inc.	Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
EP1464333A3 (en) *	1998-06-15	2004-12-15	Sepracor Inc.	Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
JP2003522103A (ja) *	1998-06-15	2003-07-22	セプラコアインコーポレーテッド	無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（−）−ノルシスアプリドの使用
US6362202B1 (en)	1999-03-02	2002-03-26	Sepracor Inc.	Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en)	1999-03-02	2002-03-05	Sepracor, Inc.	Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
CN100553636C (zh) *	2000-08-04	2009-10-28	Dmi生物科学公司	二酮基哌嗪和包含它们的组合物的使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE460359B (sv) *	1984-01-25	1989-10-02	Glaxo Group Ltd	3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4695578A (en) *	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
GB8627909D0 (en) *	1986-11-21	1986-12-31	Glaxo Group Ltd	Medicaments
GB8816187D0 (en) *	1988-07-07	1988-08-10	Glaxo Group Ltd	Medicaments
GB8914804D0 (en) *	1989-06-28	1989-08-16	Glaxo Group Ltd	Process
US5166145A (en) *	1990-09-10	1992-11-24	Alza Corporation	Antiemetic therapy

1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en not_active Ceased
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown

Also Published As

Publication number	Publication date
GB9409835D0 (en)	1994-07-06
SG48119A1 (en)	1998-04-17
AU6970994A (en)	1994-12-20
HU227121B1 (en)	2010-07-28
PL175578B1 (pl)	1999-01-29
AU680918B2 (en)	1997-08-14
HRP940315B1 (en)	2000-12-31
NO954783D0 (no)	1995-11-24
NZ267415A (en)	1997-10-24
KR100297212B1 (ko)	2001-10-24
EP0700290A1 (en)	1996-03-13
US5741806A (en)	1998-04-21
HUT74867A (en)	1997-02-28
HU9503375D0 (en)	1996-01-29
PE13395A1 (es)	1995-05-25
SI0700290T1 (en)	1999-12-31
JPH08510457A (ja)	1996-11-05
CZ291041B6 (cs)	2002-12-11
DE69420266D1 (de)	1999-09-30
BE1007158A3 (fr)	1995-04-11
DK0700290T3 (da)	2000-03-13
CZ308595A3 (en)	1996-06-12
GB2279008A (en)	1994-12-21
JP2965703B2 (ja)	1999-10-18
CA2162919C (en)	1999-07-20
ATE183643T1 (de)	1999-09-15
IS1868B (is)	2003-05-02
CN1106194C (zh)	2003-04-23
NO954783L (no)	1995-11-24
AP544A (en)	1996-10-11
CN1124454A (zh)	1996-06-12
HRP940315A2 (en)	1996-08-31
GR3031669T3 (en)	2000-02-29
CO4230094A1 (es)	1995-10-19
IE80632B1 (en)	1998-10-21
HRP970315A2 (en)	1999-04-30
CA2162919A1 (en)	1994-12-08
GB9310756D0 (en)	1993-07-14
ZA943593B (en)	1995-02-13
MY111445A (en)	2000-05-31
ITRM940322A1 (it)	1995-11-24
AP9400643A0 (en)	1994-07-31
IE940420A1 (en)	1994-11-30
FR2705569A1 (fr)	1994-12-02
BR1100046A (pt)	1999-11-23
IL109749A0 (en)	1994-08-26
WO1994027599A1 (en)	1994-12-08
GB2279008B (en)	1997-06-18
IL109749A (en)	1999-03-12
IS4168A (is)	1994-11-26
ECSP941088A (es)	1994-11-16
EP0700290B1 (en)	1999-08-25
DE69420266T2 (de)	1999-12-09
SA94150003B1 (ar)	2005-04-11
IT1272990B (it)	1997-07-01
ES2136198T3 (es)	1999-11-16
RU2132684C1 (ru)	1999-07-10
NO306448B1 (no)	1999-11-08
PL311721A1 (en)	1996-03-04
CY2411B1 (en)	2004-11-12
FR2705569B1 (fr)	1995-11-10

Legal Events

Date	Code	Title	Description
1997-07-01	0001	Granted
1999-10-27	TA	Fee payment date (situation as of event date), data collected since 19931001	Effective date: 19970530

Publication	Publication Date	Title
IT9048260A0 (it)	1990-09-07	Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ITRM940325A0 (it)	1994-05-24	"composizioni stabilizzanti per la lavorazione delle materie polimere"
BR9406128A (pt)	1996-02-27	Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica
MX9704030A (es)	1998-02-28	1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
NO305903B1 (no)	1999-08-16	Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
IT1295645B1 (it)	1999-05-24	Apparecchio per l'elettroemanazione di principi attivi.
PT754407E (pt)	2002-06-28	Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
NO942303D0 (no)	1994-06-17	Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI974640A0 (fi)	1997-12-30	Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
IT1292552B1 (it)	1999-02-08	Dispositivo per l'applicazione di rivestimenti.
ITRM940322A0 (it)	1994-05-24	"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
CA2135709A1 (en)	1995-05-19	Melatonin derivatives for use in treating sleep disorders
FR2718013B1 (fr)	1996-06-07	Dispositif d'enclouage centro-médullaire notamment pour fractures sous cervicales du fémur.
AU5053296A (en)	1996-10-17	Pharmaceutical agents for the treatment of Alzheimer's disease
IT1271567B (it)	1997-05-30	Procedimento per l'ulteriore trattamento di salcicce
IT1270905B (it)	1997-05-13	Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
IT1288399B1 (it)	1998-09-22	Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
HUP9702293A3 (en)	2000-08-28	4-thiazolidinone, rhodanine and 1,3-oxathiolan-5-one derivatives for the preparation of pharmaceutical compositions suitable for the treatment of multiple sclerosis
AU5963396A (en)	1996-12-30	Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
BR9610851A (pt)	1999-07-13	Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
IL110780A0 (en)	1994-11-11	Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
ITRM940806A0 (it)	1994-12-15	Preparato per il trattamento dell'obesita'
BR9507732A (pt)	1997-08-19	Composição farmacêutica para o tratamento de glaucoma
IT1277117B1 (it)	1997-11-04	Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
ITMI931371A1 (it)	1994-12-25	Procedimento per la preparazione dell'erdosteina